Bupivacaine hydrochloride; lidocaine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bupivacaine hydrochloride; lidocaine hydrochloride and what is the scope of patent protection?
Bupivacaine hydrochloride; lidocaine hydrochloride
is the generic ingredient in one branded drug marketed by Amphastar Pharms Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for bupivacaine hydrochloride; lidocaine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 225 |
DailyMed Link: | bupivacaine hydrochloride; lidocaine hydrochloride at DailyMed |
Recent Clinical Trials for bupivacaine hydrochloride; lidocaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Montefiore Medical Center | N/A |
Jessyka Lighthall | Phase 3 |
Jamia Millia Islamia | N/A |
See all bupivacaine hydrochloride; lidocaine hydrochloride clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for bupivacaine hydrochloride; lidocaine hydrochloride
US Patents and Regulatory Information for bupivacaine hydrochloride; lidocaine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharms Inc | DUOCAINE | bupivacaine hydrochloride; lidocaine hydrochloride | INJECTABLE;INJECTION | 021496-001 | May 23, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |